I am a child and adolescent psychiatrist specializing in neurodevelopmental disorders, including autism spectrum disorder (ASD), fragile X syndrome (FXS); attention-deficit/hyperactivity disorder (ADHD), and mood disorders. I currently serve as the Medical Director of the Transcranial Magnetic Stimulation (TMS) Center, where we provide state of the art, evidence-based care for patients and individuals with depression or anxiety disorders, including those with neurodevelopmental needs.
My clinical approach is holistic and personalized, integrating biological, psychological, and social factors that influence mental health. My interest in this work stems from formative mentorship during medical school and residency, where I learned to prioritize social determinants of health and their impact on behavior, development, and access to care. My practice is grounded in evidence-based treatment and delivered with empathy and collaboration.
As a researcher, my work focuses on TMS safety, tolerability, and efficacy in adolescents with treatment-resistant depression, with a particular emphasis on youth with ASD and other neurodevelopmental conditions. My research aims to expand access to neuromodulation as a developmentally appropriate, mid-level intervention for populations with limited effective treatment options.
It is an honor to have received several awards recognizing my clinical, research, and teaching contributions, including the AACAP Junior Investigator Award, an AACAP Pilot Research Grant, the Howard Rome Research Award from the Mayo Clinic, and the Harold Lawn Teacher of the Year Award from the University of Minnesota. I was also nominated to and served as a Resident Fellow Member Trustee on the American Psychiatric Association Board of Trustees.
MD: Weill Cornell Medicine-Qatar, 2016,
Residency: General Psychiatry, University of Minnesota, Minneapolis, MN, 2019,
Fellowship: Child and Adolescent Psychiatry, Mayo Clinic, Rochester, MN, 2021,
Neurodevelopmental disorders; autism spectrum disorders; fragile x syndrome; attention deficit hyperactivity disorder, major depressive disorder; transcranial magnetic stimulation
Transcranial magnetic stimulation; theta burst stimulation; autism; fragile x syndrome; ADHD; digital psychiatry/machine learning; EEG
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Editorial: Physical Activity and Depression in Youth: Insights From a Longitudinal Birth Cohort Study. Journal of the American Academy of Child and Adolescent Psychiatry. 2026; 65(2):158-160.
Divergent aperiodic slope and alpha dynamics expose cortical excitability gradients in fragile X syndrome. Molecular Autism. 2025; 16(1):49.
Probing the Neurodynamic Mechanisms of Cognitive Flexibility in Depressed Individuals with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 2025; 35(4):231-243.
Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55(3):940-954.
Integrated Case Presentation Seminar: Bridging Parallel Fields to Improve Psychiatry and Psychology Learner Experience. Child Psychiatry and Human Development. 2024; 55(6):1554-1563.
Risk of Newly Diagnosed Psychotic Symptoms in Youth Receiving Medications for Attention-Deficit/Hyperactivity Disorder. JAACAP Open. 2024; 2(2):135-144.
Machine Learning Identifies Smartwatch-Based Physiological Biomarker for Predicting Disruptive Behavior in Children: A Feasibility Study. Journal of Child and Adolescent Psychopharmacology. 2023; 33(9):387-392.
Harnessing Youth Engagement With Mental Health TikTok and Its Potential as a Public Health Tool. Journal of the American Academy of Child and Adolescent Psychiatry. 2023; 62(7):710-712.
Cultural Considerations in Working with Arab American Youth. Child and Adolescent Psychiatric Clinics of North America. 2022; 31(4):719-732.
A Systematic Review of the Safety and Tolerability of Theta Burst Stimulation in Children and Adolescents. Neuromodulation. 2022; 25(4):494-503.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey